Number of Biocontainment Beds for Ebola Patients in US May Surprise You

[Jerseygal]

Don't we all feel safer now?



Number of Biocontainment Beds for Ebola Patients in US May Surprise You
By ABC NEWS Oct 16, 2014, 4:47 PM
Though there is no plan yet to move all Ebola patients to specialized biocontainment facilities, only seven spots at these facilities remain open in the United States.


Ebola Survivor Dr. Kent Brantly Interview
Jack Kearse/Emory University
Health officials have said again and again that any hospital should be able to treat Ebola patients, but the two nurses diagnosed with Ebola in Dallas over the last few days have been moved from Texas Health Presbyterian Hospital -- where they contracted Ebola while treating Thomas Eric Duncan -- to specialized hospitals with biocontainment units.

There are four hospitals with biocontainment facilities in the United States, and they have 11 beds that can be used at any one time for Ebola patients, officials told ABC News. Four of those beds are currently being occupied by Ebola patients.

Dallas nurse Nina Pham, 26, was diagnosed with Ebola on Sunday and is expected to be moved to the Special Clinical Studies Unit of the NIH Clinical Center in Bethesda, Maryland. This facility has two specialized beds, Dr. Anthony Fauci, who directs the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, told Congress this afternoon.

Amber Vinson, 29, the other Dallas nurse to contract Ebola from Duncan, was diagnosed with Ebola on Wednesday and moved to Emory University Hospital in Atlanta, Georgia, later that night. Emory has three beds in its biocontainment unit.

Freelance Cameraman Ashoka Mukpo is currently being treated at Nebraska Medical Center, which has 10 specialized beds. But hospital officials told ABC News that it has the capacity to handle only up to three patients at a time.

The final hospital with a specialized biocontainment unit is St. Patrick Hospital in Missoula, Montana, which has the capacity to handle three patients. It is treating no Ebola patients at this time.

Once these spots run out, Ebola patients will be treated where they are, and officials from the Centers for Disease Control and Prevention will be dispatched to help care for them and make sure precautions are taken to ensure that no one else contracts the deadly virus, said CDC spokeswoman Barbara Reynolds.


http://abcnews.go.com/Health/us-capacity-11-ebola-patients-speciali...

[Robin]

Oh My Gosh! 11 beds and 4 occupied! This is NOT good to read at all, JG! 

[RNhunter]

Breaking News ....

WHO, the World Health Organization, has now professionally criticized the CDC (Crew of Damaging Clowns) for seemingly not knowing Ebola from a wombat or even a dangling participle. The White House Young Democrats (WHY) dismissed that statement, claiming that the WHO is guessing, which I believe would then make them the "Guess Who," thereupon asking them to please sing "Star Baby" - one of their big hits. But things got worse when the WTF (World Truth Foundation) determined that recent White House reports were even lower standards than from the Nigerian Phishing Homegroup Union of Cartels (PHUC). It is expected that the crew clowns (CDC) will soon be dispatched to the BUS (Bureaucrat Unpackaging Service) for disposition.

[NativeCollector]

That is a very grim fact, should this get more out of control. It's only here because Obama and company encouraged immigration from those 'hot spot' countries. He gets to 'feel good' while we the people get to 'feel exposed.'

[Robin]

There is really something not right about all of this! He has to bring Ebola here. I feel that is why he won't stop travel. Call me what you want! There is no other explanation! I found that the US has a patent on Ebola. 

US Govt Holds Patent on Ebola, But Researcher Rejects Conspiracy Th...

I also found this! 

Ebola Update! Very Suspicious! Crucell Vaccine Kept Hidden!

•Crucell is developing an Ebola vaccine in collaboration with the Vaccine Research Center (VRC) of the NIH National Institute of Allergy and Infectious Diseases (NIAID). It has been shown to completely protect monkeys against the virus with a single dose of the vaccine.

•Under the terms of the agreement with VRC, Crucell has an option for exclusive worldwide commercialization rights to the Ebola vaccine.

•Crucell’s Ebola vaccine entered Phase I clinical trials in Q3 2006. Two groups of 16 volunteers were enrolled and vaccinated. The study showed safety and immunogenicity at the doses evaluated.

•In October 2008, Crucell secured a NIAID/NIH award to advance the development of Ebola and Marburg vaccines, with the ultimate aim of developing a multivalent filovirus vaccine.

•The award provides funding of up to $30 million, with additional options, worth a further $40 million.”

http://investmentwatchblog.com/ebola-update-very-suspicious-crucell...